GNH USA

Europe — EMA

Momil (Mometasone Furoate)

GNH USA supplies Momil (Mometasone Furoate), a nasal corticosteroid for allergic rhinitis and nasal polyps. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Mometasone Furoate?

Mometasone furoate, the active ingredient in Momil, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation in the nasal passages and is indicated for the management of seasonal and perennial allergic rhinitis, as well as other nasal inflammatory conditions, and is marketed in the European Union.

GNH USA supplies Momil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas, ensuring regulatory compliance and product quality.

What is Mometasone Furoate used for?

Mometasone furoate nasal spray is used to treat inflammatory conditions of the nasal mucosa, primarily allergic rhinitis.

- Seasonal allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. - Perennial allergic rhinitis: provides sustained relief of chronic nasal inflammation. - Nasal polyps: helps shrink polyps and improve nasal airflow.

What are the side effects of Mometasone Furoate?

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation or dryness. - Cough. - Altered taste or taste disturbance.

Serious or Rare Side Effects: - Nasal septal perforation. - Cataracts or increased intra‑ocular pressure (glaucoma). - Suppression of the hypothalamic‑pituitary‑adrenal axis. - Opportunistic fungal infection of the nasal passages. - Severe allergic reactions such as angioedema. - Systemic corticosteroid effects with prolonged high‑dose use.

What precautions apply to Mometasone Furoate?

Before using Momil, consider the following safety measures.

- Prescription guidance: use exactly as directed by a healthcare professional. - Recent nasal surgery or trauma: avoid use until healed. - Active infections: defer use if there is a nasal or systemic infection. - Adrenal suppression: monitor patients on long‑term or high‑dose therapy. - Prolonged use: limit duration without medical review. - Device hygiene: keep the spray tip clean and replace if damaged. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Mometasone Furoate interact with?

Mometasone furoate nasal spray can interact with other medications.

Major Interactions (Avoid): - Systemic corticosteroids: increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy due to immunosuppression.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., erythromycin): may modestly increase exposure. - Antifungal azoles (e.g., fluconazole): monitor for enhanced local effects.

Frequently asked questions

What conditions is Momil used to treat?+
Momil contains mometasone furoate, a nasal corticosteroid indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis as well as for the management of nasal polyps. It works by reducing inflammation within the nasal passages, helping to alleviate congestion, sneezing, itching and nasal obstruction.
How does mometasone furoate work in the nose?+
Mometasone furoate is an agonist of the glucocorticoid receptor. After binding to the receptor inside nasal mucosal cells, it alters gene transcription, suppressing the production of inflammatory cytokines, chemokines and adhesion molecules. This reduces swelling, mucus production and the infiltration of inflammatory cells, providing anti‑inflammatory and immunosuppressive effects locally.
What is the usual dose of Momil?+
The specific dosing regimen for Momil is determined by the prescribing clinician based on the patient’s age, severity of symptoms and overall treatment plan. Healthcare providers will instruct the number of sprays per nostril and the frequency of administration, and patients should follow that guidance precisely.
Is Momil safe to use during pregnancy or breastfeeding?+
Safety data for mometasone furoate nasal spray in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their obstetrician or healthcare provider.
How do I order Momil from GNH USA?+
To request Momil, visit the product page on gnh-usa.com, enter the required quantity and submit the enquiry form. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.
How does Momil compare with other nasal corticosteroids?+
Momil (mometasone furoate) is a high‑potency intranasal corticosteroid with a low systemic bioavailability, similar to other agents such as fluticasone propionate or budesonide. Clinical studies suggest comparable efficacy in controlling allergic rhinitis symptoms, while its once‑daily dosing and favorable safety profile make it a convenient option for many patients.
What are the storage requirements for Momil?+
Momil should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the spray tip remains clean. Do not freeze the nasal spray.
How is Momil administered?+
Momil is administered as a nasal spray. The patient gently tilts the head forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently through the nose. The same procedure is repeated in the other nostril if directed by the prescriber.
What are the most serious risks associated with Momil?+
Serious risks, although rare, include nasal septal perforation, cataracts or increased intra‑ocular pressure, suppression of the hypothalamic‑pituitary‑adrenal axis, and opportunistic fungal infections of the nasal mucosa. Patients should report persistent nosebleeds, visual changes, severe headache or signs of systemic steroid exposure to their healthcare provider promptly.
Who should not use Momil?+
Momil is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with recent nasal surgery, severe nasal trauma, or active untreated nasal infections unless directed by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mometasone Furoate
Route
Nasal Use
Manufacturer
Laboratorio Chimico Deca Dr. Capuani S.R.L.
Origin
EU

Related products